{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T20:13:00Z","timestamp":1785010380265,"version":"3.55.0"},"reference-count":34,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"3","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Background: Neonatal hypoxic-ischemic encephalopathy (HIE) is a serious condition that can lead to long-term neurological damage. Mild hypothermia is a promising treatment for HIE, but its efficacy and safety in newborns are not well established. To evaluate the therapeutic effects of mild hypothermia on neonatal HIE in a randomised controlled trial. Methods: This was a prospective study of 132 newborns with HIE treated with either mild hypothermia or routine conventional treatment. The primary outcome measures were changes in neural cytokines, brain injury markers, oxidative stress factors, neurological function recovery time, and therapeutic outcomes. Results: The mild hypothermia group showed significant improvements in neural cytokines (NGF and BDNF), brain injury markers (S100B, NSE, and MBP), and oxidative stress factors (SOD, MDA, IL-18, and caspase-3) compared to the control group. The mild hypothermia group also had a faster neurological function recovery time and a higher total response rate (95.45% vs. 80.30%, P&lt;0.05) compared to the control group. Conclusions: Mild hypothermia therapy is a safe and effective treatment for neonatal HIE, with significant improvements in neural cytokines, brain injury markers, and oxidative stress factors, as well as faster neurological function recovery time and higher therapeutic outcomes. Results: The mild hypothermia group showed significant improvements in neural cytokines (NGF and BDNF), brain injury markers (S100B, NSE, and MBP), and oxidative stress factors (SOD, MDA, IL-18, and caspase-3) compared to the control group. The mild hypothermia group also had a faster neurological function recovery time and a higher total response rate (95.45% vs. 80.30%, P&lt;0.05) compared to the control group. Conclusions: Mild hypothermia therapy is a safe and effective treatment for neonatal HIE, with significant improvements in neural cytokines, brain injury markers, and oxidative stress factors, as well as faster neurological function recovery time and higher therapeutic outcomes. The novelty of this work was that it showed potential biomarkers for evaluating response to treatment and the pathophysiological effect of treatment by assessing these biomarkers.<\/jats:p>","DOI":"10.5937\/jomb0-50866","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:10:16Z","timestamp":1735895416000},"page":"515-523","source":"Crossref","is-referenced-by-count":1,"title":["Mild hypothermia effects on serum neuroprotection, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and superoxide dismutase (SOD) levels in neonates with hypoxic-ischemic encephalopathy"],"prefix":"10.5937","volume":"44","author":[{"given":"Wenfeng","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Zhou Y, Sun L, Wang H. Ketogenic diet for neonatal hypoxic-ischemic encephalopathy. ACS Chem Neurosci 2023; 14(1): 1-8;","DOI":"10.1021\/acschemneuro.2c00609"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Satar M, Okulu E, Y\u0131ld\u0131zda HY. Editorial: New perspectives of hypoxic ischemic encephalopathy. Front Pediatr 2023; 11: 1251446(1-3);","DOI":"10.3389\/fped.2023.1251446"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ravikumar C, Pandey R. Feeding infants with hypoxic ischemic encephalopathy during therapeutic hypothermia. J Perinatol 2023; 43(1): 124-7;","DOI":"10.1038\/s41372-022-01520-4"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Zhou KQ, Dhillon SK, Bennet L, Gunn AJ, Davidson JO. Targeting persistent neuroinflammation after hypoxic-ischemic encephalopathy-is exendin-4 the answer? Int J Mol Sci 2022; 23(17): 10191(1-13);","DOI":"10.3390\/ijms231710191"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"D' angelo G, Cannav\u00f2 L, Reiter RJ, Gitto E. Melatonin administration from 2000 to 2020 to human newborns with hypoxic-ischemic encephalopathy. Am J Perinatol 2022; 39(8): 824-9;","DOI":"10.1055\/s-0040-1719151"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Imanishi T, Shimizu M, Sumiya W, Kanno C, Kanno M, Kanno M, Kawabata K. Brain injury following mild hypoxic-ischemic encephalopathy in neonates-Ten-year experience in a tertiary perinatal center. J Perinatol 2022; 42(12): 1630-6;","DOI":"10.1038\/s41372-022-01486-3"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Berska J, Bugajska J, Sztefko K. The accuracy of serum osmolarity calculation in small children. J Med Biochem 2023; 42 (1): 67-77;","DOI":"10.5937\/jomb0-37490"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Li B, Dasgupta C, Huang L, Meng X, Zhang L. MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy. Cell Mol Immunol 2020; 17(9): 976-91;","DOI":"10.1038\/s41423-019-0257-6"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Herz J, Bendix I, Felderhoff-M\u00fcser U. Peripheral immune cells and perinatal brain injury: a double-edged sword? Pediatr Res 2022; 91(2): 392-403;","DOI":"10.1038\/s41390-021-01818-7"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Xin Y , Tian M, Deng S, Li J, Y ang M, Gao J, Pei X, Wang Y , T an J, Zhao F , Gao Y , Gong Y . The key drivers of brain injury by systemic inflammatory responses after sepsis: Microglia and neuroinflammation. Mol Neurobiol 2023; 60(3): 1369-90;","DOI":"10.1007\/s12035-022-03148-z"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Chen HR, Chen CW, Kuo YM, Chen B, Kuan IS, Huang H, Lee J, Anthony N, Kuan CY , Sun YY . Monocytes promote acute neuroinflammation and become pathological microglia in neonatal hypoxic-ischemic brain injury. Theranostics 2022; 12(2): 512-29;","DOI":"10.7150\/thno.64033"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Sechi G, Sechi MM. New therapeutic paradigms in neonatal hypoxic-ischemic encephalopathy. ACS Chem Neurosci 2023; 14(6): 1004-6;","DOI":"10.1021\/acschemneuro.3c00029"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Tetarbe M, Wisnowski JL, Geyer E, Tamrazi B, Wood T, Mietzsch U, Bl\u00fcml S, Wu TW. Cerebral glucose concentration in neonatal hypoxic-ischemic encephalopathy during therapeutic hypothermia. J Pediatr 2023; 261: 113560(1-8);","DOI":"10.1016\/j.jpeds.2023.113560"},{"key":"ref14","unstructured":"Shankaran S, Pappas A, McDonald SA, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 2012; 366(22): 2085-92. doi: 10.1056\/NEJMoa1110380;"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. The Lancet 2005 Feb 19; 365(9460): 663-70;","DOI":"10.1016\/S0140-6736(05)70932-6"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Hu Y, Wang P , Han K. Hydrogen attenuated inflammation response and oxidative in hypoxic ischemic encephalopathy via Nrf2 mediated the inhibition of NLRP3 and NF-B. Neuroscience 2022; 485: 23-36;","DOI":"10.1016\/j.neuroscience.2021.12.024"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kumar J, Anne RP, Meena J, Sundaram V, Dutta S, Kumar P. To feed or not to feed during therapeutic hypothermia in asphyxiated neonates: a systematic review and meta-analysis. Eur J Pediatr 2023; 182(6): 2759-73;","DOI":"10.1007\/s00431-023-04950-0"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Bendall A, Schreiber V , Crawford K, Kumar S. Predictive utility of the fetal cerebroplacental ratio for hypoxic ischaemic encephalopathy, severe neonatal morbidity and perinatal mortality in late-preterm and term infants. Aust N Z J Obstet Gynaecol 2023; 63(4): 491-8;","DOI":"10.1111\/ajo.13668"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Samir A, Nasef N, Fathy K, El-Gilany AH, Y ahia S. Effect of cerebrolysin on neurodevelopmental outcome of high risk preterm infants: a randomised controlled trial. Journal of Neonatal-Perinatal Medicine 2022 Jan 1; 15(1): 37-45;","DOI":"10.3233\/NPM-200659"},{"key":"ref20","unstructured":"Bao XL, Yu RJ, Li ZS. 20-item neonatal behavioral neurological assessment used in predicting prognosis of asphyxiated newborn. Chinese Medical Journal 1993; 106(03): 211-5;"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Azzopardi D, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361(14): 1349-58. doi: 10.1056\/NEJMoa0900854;","DOI":"10.1056\/NEJMoa0900854"},{"key":"ref22","unstructured":"Zhou WH, Cheng GQ, Shao XM, et al. Mild hypothermia therapy for neonatal hypoxic-ischemic encephalopathy: a randomised controlled trial. Chin Med J (Engl) 2010; 123(11): 1458-64;"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Huan Y, Quan H, Jia B, Hao G, Shi Z, Zhao T , Yuan Y, Yuan F , Dong Y , Liang G. High-altitude cerebral hypoxia promotes mitochondrial dysfunction and apoptosis of mouse neurons. Front Mol Neurosci 2023; 16: 1216947(1-11);","DOI":"10.3389\/fnmol.2023.1216947"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhao J, Le M, Li J, Huang Q, Chen H, Zhang W , Mao H, Sun Q, Li A, Zhao Y , Yu L, Yi M, Wang J, Li X, Zhang G, Ma J, Dong X. LINC00938 alleviates hypoxia ischemia encephalopathy induced neonatal brain injury by regulating oxidative stress and inhibiting JNK\/p38 MAPK signaling pathway. Exp Neurol 2023; 367: 114449(1-13);","DOI":"10.1016\/j.expneurol.2023.114449"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Imataka G, Fujita Y , Kikuchi J, Wake K, Ono K, Y oshihara S. Brain hypothermia therapy and targeted temperature management for acute encephalopathy in children: Status and prospects. J Clin Med 2023; 12(6): 2095(1-14);","DOI":"10.3390\/jcm12062095"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ahmed J, Robertson NJ, More K. Melatonin for neuroprotection in neonatal encephalopathy: A systematic review & meta-analysis of clinical trials. European Journal of Paediatric Neurology 2021 Mar 1; 31: 38-45;","DOI":"10.1016\/j.ejpn.2021.02.003"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Aly H, Elmahdy H, El-Dib M, Rowisha M, Awny M, El-Gohary T, Elbatch M, Hamisa M, El-Mashad AR. Melatonin use for neuroprotection in perinatal asphyxia: a randomised controlled pilot study. Journal of Perinatology 2015 Mar; 35(3): 186-91;","DOI":"10.1038\/jp.2014.186"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Barata L, Arruza L, Rodr\u00edguez MJ, Aleo E, Vierge E, Criado E, Sobrino E, Vargas C, Cepri\u00e1n M, Guti\u00e9rrez-Rodr\u00edguez A, Hind W. Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage. Neuropharmacology 2019 Mar 1; 146: 1-11;","DOI":"10.1016\/j.neuropharm.2018.11.020"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Zhu C, Kang W , Xu F , Cheng X, Zhang Z, Jia L, Ji L, Guo X, Xiong H, Simbruner G, Blomgren K. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009 Aug 1; 124(2): e218-26;","DOI":"10.1542\/peds.2008-3553"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Chen CR, Bi HL, Li X, Li ZM. Remifentanil protects neurological function of rats with cerebral ischemia-reperfusion injury via NR2B\/CaMKII signaling pathway. J Biol Regul Homeost Agents 2020; 34(5): 1647-56;","DOI":"10.23812\/20-169-A"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Weng B, Y an C, Chen Y , Gong X, Cai C. Efficiency evaluation of neuroprotection for therapeutic hypothermia to neonatal hypoxic-ischemic encephalopathy. Front Neurosci 2021; 15:668909(1-7);","DOI":"10.3389\/fnins.2021.668909"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Tang X, Ke J, Chen F , Lin Q, You Y, Zheng N, Gong Z, Han X, Zhuang Y , Chen F . Hypoxic preconditioned mesenchymal stem cells ameliorate rat brain injury after cardiopulmonary resuscitation by suppressing neuronal pyroptosis. J Cell Mol Med 2023; 27(13): 1836-58;","DOI":"10.1111\/jcmm.17782"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Xue LL, Du RL, Hu Y, Xiong LL, Su ZY, Ma Z, T an YX, Liu J, Hu Q, Zhu ZQ, Liu XZ, Wang TH. BDNF promotes neuronal survival after neonatal hypoxic-ischemic encephalopathy by up-regulating Stx1b and suppressing VDAC1. Brain Res Bull, 2021; 174: 131-40;","DOI":"10.1016\/j.brainresbull.2021.05.013"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wang J, Hua M, Li H, Xu D, Li F , Xu F . Circ_0007706 downregulation ameliorates neonatal hypoxic ischemic encephalopathy via regulating the miR-579-3p\/TRAF6 axis. Brain Res Bull 2023; 194: 90-9;","DOI":"10.1016\/j.brainresbull.2023.01.013"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Uticaj blage hipotermije na nivo serumskih neuroprotektivnih faktora, faktora rasta nerva (NGF), neurotrofnog mo\u017edanog faktora (BDNF) i superoksid-dismutaze (SOD) kod novoro\u0111en\u010dadi sa hipoksi\u010dno-ishemi\u010dnom encefalopatijom"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/50866\/26823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582503515D.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T16:49:17Z","timestamp":1749833357000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582503515D"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-50866","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}